PTEN loss induces NRP2 transcription in prostate cancer by a mechanism that involves the Jun N-terminal kinase (JNK)/c-jun pathway, providing a direct link between the loss of a tumor suppressor and induction of NRP2 transcription [34]. Here, NRP2 is linked to prostate cancer.